Transport and killing mechanism of a novel camptothecin-deoxycholic acid derivate on hepatocellular carcinoma cells

References

• Farmer DG, Rosove MH, Shaked A, Busuttil RW. Current treatment modalities for hepatocellular carcinoma. Ann Surg 1994;219:236–47
   PubMed Web of Science ®Google Scholar
• Wall ME, Wani MC, Cook CE, et al. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from camptotheca acuminata. J Am Chem Soc 1966;88:3888–90
   Web of Science ®Google Scholar
• Bomgaars L, Berg SL, Blaney SM. The development of camptothecin analogs in childhood cancers. Oncologist 2001;6:506–16
   PubMed Web of Science ®Google Scholar
• Dancey J, Eisenhauer EA. Current perspectives on camptothecins in cancer treatment. Br J Cancer 1996;74:327–38
   PubMed Web of Science ®Google Scholar
• Li QY, Zu YG, Shi RZ, Yao LP. Review camptothecin: current perspectives. Curr Med Chem 2006;13:2021–39
   PubMed Web of Science ®Google Scholar
• He X, Lu W, Jiang X, et al. Synthesis and biological evaluation of bis and monocarbonate prodrugs of 10-hydroxycamptothecins. Bioorg Med Chem 2004;12:4003–8
   Google Scholar
• Kramer W, Wess G. Bile acid transport systems as pharmaceutical targets. Eur J Clin Invest 1996;26:715–32
   PubMed Web of Science ®Google Scholar
• Monte MJ, Dominguez S, Palomero MF, et al. Further evidence of the usefulness of bile acids as molecules for shuttling cytostatic drugs toward liver tumors. J Hepatol 1999;31:521–8
   PubMed Web of Science ®Google Scholar
• Sievänen E. Exploitation of bile acid transport systems in prodrug design. Molecules 2007;12:1859–89
   PubMed Web of Science ®Google Scholar
• Yang C, Tiruchera GS, Mitra AK. Prodrug based optimal drug delivery via membrane transporter/receptor. Expert Opin Biol Ther 2001;1:159–75
   PubMed Web of Science ®Google Scholar
• Zheng X, Polli JE. Synthesis and in vitro evaluation of potential sustained release prodrugs via targeting ASBT. Int J Pharm 2010;396:111–18
   PubMedGoogle Scholar
• Niemi M, Pasanen MK, Neuvonen PJ. Organic anion transporting polypeptide1B1: a genetically polymorphic transporter of major importance forhepatic drug uptake. Pharmacol Rev 2011;63:157–81
   PubMed Web of Science ®Google Scholar
• Obaidat A, Roth M, Hagenbuch B. The expression and function of organic anion transporting polypeptides in normal tissues and in cancer. Annu Rev Pharmacol Toxicol 2012;52:135–51
   PubMed Web of Science ®Google Scholar
• Nozawa T, Minami H, Sugiura S, et al. Role of organic anion transporter OATP1B1 in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms. Drug Metab Dispos 2005;33:434–9
   PubMed Web of Science ®Google Scholar
• Oostendorp RL, Van de Steeg E, Van der Kruijssen CM, et al. Organic anion-transporting polypeptide 1B1 mediates transport of Gimatecan and BNP1350 and can be inhibited by several classic ATP-binding cassette B1 and/or ABCG2 inhibitors. Drug Metab Dispos 2009;37:917–23
   PubMed Web of Science ®Google Scholar
• König J, Cui Y, Nies AT, Keppler D. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol Gastrointest Liver Physiol 2000;278:G156–64
   PubMed Web of Science ®Google Scholar
• Liu TY, Li QY. Organic anion-transporting polypeptides: a novel approach for cancer therapy. J Drug Target 2014;22:14–22
   PubMed Web of Science ®Google Scholar
• Li QY, Gao Y, Qiu W, et al. Synthesis and anti-tumor activity of novel camptothecin-bile acid analogues. Lett Drug Discov 2011;8:698–703
   Web of Science ®Google Scholar
• Kato K, Shirasaka Y, Kuraoka E, et al. Intestinal absorption mechanism of tebipenem pivoxil, a novel oral carbapenem: involvement of human OATP family in apical membrane transport. Mol Pharm 2010;7:1747–56
   PubMed Web of Science ®Google Scholar
• St-Pierre MV, KuLlak-Ublick GA, Hagenbuch B, Meier PJ. 2001. Transport of bile acids in hepatic and non-hepatic tissues. J Exp Biol 204:1673–86
   Google Scholar
• Bednarczyk D. Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3. Anal Biochem 2010;405:50–8
   PubMed Web of Science ®Google Scholar
• Karlgren M, Vildhede A, Norinder U, et al. Classification of inhibitors of hepatic organic anion transporting polypeptides: influence of protein expression on drug–drug interactions. J Med Chem 2012;55:4740–63
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Ceryak S, Matsuzaki Y, et al. Effect of bile acids on the uptake of irinotecan and its active metabolite, SN-38, by intestinal cells. Biochim Biophys Acta 2001;1525:125–9
   PubMed Web of Science ®Google Scholar
• Briz O, Romero MR, Martinez-Becerra P, et al. OATP8/1B3-mediated cotransport of bile acids and glutathione: an export pathway for organic anions from hepatocytes? J Biol Chem 2006;281:30326–35
   PubMed Web of Science ®Google Scholar
• Lansiaux A, Léonce S, Kraus-Berthier L, et al. Novel stable camptothecin derivatives replacing the E-ring lactone by a ketone function are potent inhibitors of topoisomerase I and promising antitumor drugs. Mol Pharmacol 2007;72:311–19
   PubMed Web of Science ®Google Scholar
• Li QY, Qiu W, Zhu QC, et al. Camptothecin-20-O-[N-]-lysine, a novel camptothecin analogue,induces apoptosis towards hepatocellular carcinoma SMMC-7721 cells. Molecules 2011;16:7803–14
   PubMed Web of Science ®Google Scholar
• Evenson DP, Jost LK, Baer RK, et al. Individuality of DNA denaturation patterns in human sperm as measured by the sperm chromatin structure assay. Reprod Toxicol 1991;5:115–25
   PubMed Web of Science ®Google Scholar
• Zhang Y, Luo M, Zu YG, et al. Dryofragin, a phloroglucinol derivative, induces apoptosis in human breast cancer MCF-7 cells through ROS-mediated mitochondrial pathway. Chem Biol Interact 2012;199:129–36
   PubMed Web of Science ®Google Scholar
• Gao LW, Zhang J, Yang WH, et al. Glaucocalyxin A induces apoptosis in human leukemia HL-60 cells through mitochondria-mediated death pathway. Toxicol In Vitro 2011;25:51–63
   PubMed Web of Science ®Google Scholar
• López-Royuela N, Pérez-Galán P, Galán-Malo P, et al. Different contribution of BH3-only proteins and caspases to doxorubicin-induced apoptosis in p53-deficient leukemia cells. Biochem Pharmacol 2010;79:1746–58
   PubMed Web of Science ®Google Scholar
• de Murcia G, Ménissier de Murcia J. Poly polymerase, a molecular nick-sensor. Trends Biochem Sci 1994;19:172–6
   PubMed Web of Science ®Google Scholar
• Rouleau M, Patel A, Hendzel MJ, et al. PARP inhibition: PARP1 and beyond. Nat Rev Cancer 2010;10:293–301
   PubMed Web of Science ®Google Scholar
• D'Arpa P, Beardmore C, Liu LF. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. Cancer Res 1990;50:6919–24
   PubMed Web of Science ®Google Scholar
• Staker BL, Hjerrild K, Feese MD, et al. The mechanism of topoisomerase I poisoning by a camptothecin analog. Proc Natl Acad Sci USA 2002;99:15387–92
   PubMed Web of Science ®Google Scholar
• Wang X, Zhou X, Hecht SM. Role of the 20-hydroxyl group in camptothecin binding by the topoisomerase I-DNA binary complex. Biochemistry 1999;38:4374–81
   PubMed Web of Science ®Google Scholar
• Hertzberg RP, Caranfa MJ, Holden KG, et al. Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity. J Med Chem 1989;32:715–20
   PubMed Web of Science ®Google Scholar